CD19 CAR-T expressing PD-1/CD28 chimeric switch receptor as a salvage therapy for DLBCL patients treated with different CD19-directed CAR T-cell therapies. #lymphoma #lymsm https://t.co/XHOQHURRAE
2,454 followers
251 followers
RT @CARTTherapy: CD19 #CAR-T expressing PD-1/CD28 chimeric switch receptor as a salvage therapy for DLBCL patients treated with different C…
925 followers
New article: CD19 CAR-T expressing PD-1/CD28 chimeric switch receptor as a salvage therapy for DLBCL patients treated with different CD19-directed CAR T-cell therapies. https://t.co/6HiTOhByYT #DLBCL #lymsm #hematology https://t.co/AT6LN93cpE
1,972 followers
RT @CARTTherapy: CD19 #CAR-T expressing PD-1/CD28 chimeric switch receptor as a salvage therapy for DLBCL patients treated with different C…